Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 270

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

Open access
Zhai, Y, Guo, R, Hsu, T L, Yu, G L, Ni, J, Kwon, B S, Jiang, G W, Lu, J, Tan, J, Ugustus, M, Carter, K, Rojas, L, Zhu, F, Lincoln, C, Endress, G, Xing, L, Wang, S, Oh, K O, Gentz, R, Ruben, S, Lippman, M E, Hsieh, S L, Yang, D·1998·Journal of Clinical Investigation

Abstract

LIGHT is a new member of tumor necrosis factor (TNF) cytokine family derived from an activated T cell cDNA library.LIGHT mRNA is highly expressed in splenocytes, activated PBL, CD8 ϩ tumor infiltrating lymphocytes, granulocytes, and monocytes but not in the thymus and the tumor cells examined.Introduction of LIGHT cDNA into MDA-MB-231 human breast carcinoma caused complete tumor suppression in vivo.Histological examination showed marked neutrophil infiltration and necrosis in LIGHT expressing but not in the parental or the Neo-transfected MDA-MB-231 tumors.Interferon ␥ (IFN ␥ ) dramatically enhances LIGHT-mediated apoptosis.LIGHT protein triggers apoptosis of various tumor cells expressing both lymphotoxin ␤ receptor (LT ␤ R) and TR2/HVEM receptors, and its cytotoxicity can be blocked specifically by addition of a LT ␤ R-Fc or a TR2/HVEM-Fc fusion protein.However, LIGHT was not cytolytic to the tumor cells that express only the LT ␤ R or the TR2/HVEM or hematopoietic cells examined that express only the TR2/HVEM, such as PBL, Jurkat cells, or CD8 ϩ TIL cells.In contrast, treatment of the activated PBL with LIGHT resulted in release of IFN ␥ .Our data suggest that LIGHT triggers distinct biological responses based on the expression patterns of its receptors on the target cells.Thus, LIGHT may play a role in the immune modulation and have a potential value in cancer therapy.( J. Clin.Invest.1998.102:1142-1151.)Key words: TNF • breast cancer • apoptosis • LT ␤ R • TR2/HVEM Methods Cells and reagents.Human breast cell lines (MCF-7, BT474, T47D, MDA-MB-134, and MCF10A), prostate cancer lines (PC-3 and LNCaP), human colon cancer lines (HT-29 and SW480), and human T cell Leukemia Jurkat cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD).The human breast carcinoma MDA-MB-231, a subclone 2LMP, obtained from in vivo passage of MDA-MB-231 cells in nude mice was used in all of the experiments.Human melanoma antigen-reactive CD8 ϩ T cell lines, TIL1200 and TIL1235 (21) was kindly provided by Dr. Y. Kawakami (National Cancer Institute, Bethesda, MD).All tumor cell lines were grown and maintained in the appropriate growth medium recommended by ATCC.Human PBMC were obtained from normal do-

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci3492

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Metadata

Authors
Zhai, Y., Guo, R., Hsu, T. L., Yu, G. L., Ni, J., Kwon, B. S., Jiang, G. W., Lu, J., Tan, J., Ugustus, M., Carter, K., Rojas, L., Zhu, F., Lincoln, C., Endress, G., Xing, L., Wang, S., Oh, K. O., Gentz, R., Ruben, S., Lippman, M. E., Hsieh, S. L., & Yang, D.
Venue
Journal of Clinical Investigation
Published
1998-09-15
Volume
102
Issue
6
Pages
1142-1151
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2001651353
Cited by
270
References
27
FWCI
4.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. https://app.cochat.ai/papers/10.1172/jci3492
The paper
Zhai, Y., Guo, R., Hsu, T. L., Yu, G. L., Ni, J., Kwon, B. S., Jiang, G. W., Lu, J., Tan, J., Ugustus, M., Carter, K., Rojas, L., Zhu, F., Lincoln, C., Endress, G., Xing, L., Wang, S., Oh, K. O., Gentz, R., . . . Yang, D. (1998). LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. Journal of Clinical Investigation. https://doi.org/10.1172/jci3492

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.